Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Non-Current Assets (2018 - 2025)

Dna X filings provide 8 years of Non-Current Assets readings, the most recent being $15.0 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 97.9% to $15.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $42.9 million, a 12.46% decrease, with the full-year FY2025 number at $15.0 million, up 97.9% from a year prior.
  • Non-Current Assets hit $15.0 million in Q4 2025 for Dna X, up from $9.9 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $15.3 million in Q3 2024 to a low of $710000.0 in Q1 2021.
  • Median Non-Current Assets over the past 5 years was $9.0 million (2025), compared with a mean of $8.7 million.
  • Biggest five-year swings in Non-Current Assets: crashed 47.29% in 2021 and later skyrocketed 671.83% in 2022.
  • Dna X's Non-Current Assets stood at $2.4 million in 2021, then surged by 189.49% to $6.9 million in 2022, then soared by 78.63% to $12.3 million in 2023, then plummeted by 38.2% to $7.6 million in 2024, then surged by 97.9% to $15.0 million in 2025.
  • The last three reported values for Non-Current Assets were $15.0 million (Q4 2025), $9.9 million (Q3 2025), and $9.0 million (Q2 2025) per Business Quant data.